Financing channel feed – Endpoints News

Financing channel feed

Armed with $36M A round, Johns Hopkins spinout Neuraly heads to PhI Parkinson's trial

7 years ago

By the numbers: Series A rounds are busting out, platforms are in, M&A is down, valuations surge and 2018 looks wicked big

7 years ago

Boom time: Rubius, Crinetics find big support in upsized IPOs totaling $343M raise

7 years ago

Pre-revenue vaccine developer CanSino lines up at a buzzing HKEX

7 years ago

On its way to making Hong Kong history, Ascletis eyes $457M haul in GIC-backed IPO

7 years ago

The next Nimbus? Head of billion-dollar drug program launches HotSpot with $45M A round

7 years ago

Fast-growing Ascentage has big plans for its latest $150M raise -- but what about the IPO?

7 years ago

Chasing Biogen, the Pliant crew banks a $62M round to fuel their shot at fibrosis targets

7 years ago

Backers of Tesla and SpaceX fund 29-year-old Alice Zhang's AI-powered neuroscience startup

7 years ago

A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casino

7 years ago

Vant commander Ramaswamy heads back to Nasdaq with a $150M pitch — are investors ready to forgive Axovant?

7 years ago

Biogen vet George Scangos jumps on the board at upstart MS case manager Octave, backed by Section 32

7 years ago

Thiel-backed Compass adds $49M to A round, bringing total to $132M

7 years ago

12 top China VCs you need to know who are making a transpacific splash (Part 2)

7 years ago

Forbion raises $316M to tap the potential of European biotech plays

7 years ago

As biotech funds sprout around the globe, Sanofi and government bank are setting up a $292M operation in France

7 years ago

7 things you need to know now about raising biotech cash in China (Part 1)

7 years ago

A roaring Rubius sets out to snag $1.8B market cap in $200M IPO

7 years ago

Abingworth lines up $315M to bet on a new generation of transatlantic biotechs

7 years ago

With tech from Spinraza's maker, French startup Dynacure gets $55M to tackle neuromuscular disease

7 years ago

Another IPO frenzy? Two US biotechs head to Hong Kong for a public market debut

7 years ago

Hong Kong exchange picks up steam with two biotech IPOs from Innovent, MicuRx

7 years ago

RIP XTuit: Great brains, hot target and vet CEO Deborah Dunsire in charge couldn’t stop this biotech from going down

7 years ago

With $100M in fresh backing and a new TCR initiative, Athenex launches China JV

7 years ago

First page Previous page 125 126 127128129 130 131 Next page Last page